Literature DB >> 16921127

Parker B. Francis lectureship. Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease.

David A Lomas1.   

Abstract

alpha(1)-Antitrypsin deficiency is the only genetic factor that is widely recognized to predispose smokers to chronic obstructive pulmonary disease. We have shown that the plasma deficiency results from point mutations perturbing the structure of the protein to favor sequential linkage between the reactive center loop of one molecule and beta-sheet A of another. These polymers are retained within the liver to form the periodic acid-Schiff-positive inclusions that are characteristic of the disease. Intracellular polymerization also explains the retention of mutants of other members of the serine proteinase inhibitor (or serpin) superfamily to cause diseases as diverse as thrombosis, angio-edema, and dementia. In view of the common mechanism, we have grouped these conditions together as the serpinopathies. Intrapulmonary Z alpha(1)-antitrypsin similarly forms polymers within the alveolar space. These polymers are inactive as a proteinase inhibitor and act as a chemoattractant for neutrophils. This conformational transition may explain the excessive inflammation that underlies the progressive emphysema associated with Z alpha(1)-antitrypsin deficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16921127      PMCID: PMC2643219          DOI: 10.1513/pats.200603-069MS

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  28 in total

1.  6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis.

Authors:  Ravi Mahadeva; Timothy R Dafforn; Robin W Carrell; David A Lomas
Journal:  J Biol Chem       Date:  2001-12-28       Impact factor: 5.157

Review 2.  Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.

Authors:  David A Lomas; Ravi Mahadeva
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Molecular mousetraps and the serpinopathies.

Authors:  D A Lomas; D Belorgey; M Mallya; E Miranda; K J Kinghorn; L K Sharp; R L Phillips; R Page; A S Robertson; D C Crowther
Journal:  Biochem Soc Trans       Date:  2005-04       Impact factor: 5.407

4.  Quantitative isolation of alphalAT mutant Z protein polymers from human and mouse livers and the effect of heat.

Authors:  Jae-Koo An; Keith Blomenkamp; Douglas Lindblad; Jeffrey H Teckman
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

5.  alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation.

Authors:  K O'Riordan; A Blei; M S Rao; M Abecassis
Journal:  Transplantation       Date:  1997-02-15       Impact factor: 4.939

6.  Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema.

Authors:  P R Elliott; D Bilton; D A Lomas
Journal:  Am J Respir Cell Mol Biol       Date:  1998-05       Impact factor: 6.914

7.  A kinetic mechanism for the polymerization of alpha1-antitrypsin.

Authors:  T R Dafforn; R Mahadeva; P R Elliott; P Sivasothy; D A Lomas
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

8.  Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo.

Authors:  Ravi Mahadeva; Carl Atkinson; Zhenjun Li; Susan Stewart; Sabina Janciauskiene; Diane G Kelley; Jasvir Parmar; Rebecca Pitman; Steven D Shapiro; David A Lomas
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

9.  Drosophila necrotic mutations mirror disease-associated variants of human serpins.

Authors:  Clare Green; Gemma Brown; Timothy R Dafforn; Jean-Marc Reichhart; Terri Morley; David A Lomas; David Gubb
Journal:  Development       Date:  2003-04       Impact factor: 6.868

10.  Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis.

Authors:  Javier Corral; Justo Aznar; Rocio Gonzalez-Conejero; Piedad Villa; Antonia Miñano; Amparo Vayá; Robin W Carrell; James A Huntington; Vicente Vicente
Journal:  Circulation       Date:  2004-08-30       Impact factor: 29.690

View more
  3 in total

1.  Accelerated spirometric decline in New York City firefighters with α₁-antitrypsin deficiency.

Authors:  Gisela I Banauch; Mark Brantly; Gabriel Izbicki; Charles Hall; Alan Shanske; Robert Chavko; Ganesha Santhyadka; Vasilios Christodoulou; Michael D Weiden; David J Prezant
Journal:  Chest       Date:  2010-07-15       Impact factor: 9.410

Review 2.  Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

3.  Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency.

Authors:  Caitriona McLean; Catherine M Greene; Noel G McElvaney
Journal:  Biologics       Date:  2009-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.